IPP Bureau

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

By IPP Bureau - May 25, 2026

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026

Datroway wins US nod in aggressive breast cancer subtype
Datroway wins US nod in aggressive breast cancer subtype

By IPP Bureau - May 25, 2026

Clearance marks major shift beyond chemotherapy

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

By IPP Bureau - May 25, 2026

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

By IPP Bureau - May 25, 2026

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections

WHO declares Ebola outbreak, Indians advised against travel to affected regions
WHO declares Ebola outbreak, Indians advised against travel to affected regions

By IPP Bureau - May 25, 2026

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease

Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma
Anupam Rasayan to acquire 43.3%–48.2% equity stake in Bliss GVS Pharma

By IPP Bureau - May 25, 2026

The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment

SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth
SMS Pharma posts 48% profit surge in FY26 as margins expand & portfolio shift drives growth

By IPP Bureau - May 25, 2026

Revenue from operations climbed 13% to Rs. 886.87 crore

Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President
Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President

By IPP Bureau - May 25, 2026

Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels

AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%
AstraZeneca breast cancer drug wins key EU backing after cutting progression risk by 56%

By IPP Bureau - May 25, 2026

The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial

Zota Health Care posts 83.86% revenue surge in FY26
Zota Health Care posts 83.86% revenue surge in FY26

By IPP Bureau - May 25, 2026

Expands Davaindia network to 2,579 stores

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

By IPP Bureau - May 25, 2026

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval
EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

By IPP Bureau - May 25, 2026

The decision marks a key step in the centralized EU review process

Maxivision appoints Surya K as Group Head – Medical Affairs and Quality
Maxivision appoints Surya K as Group Head – Medical Affairs and Quality

By IPP Bureau - May 23, 2026

Surya to lead medical governance, patient safety, clinical excellence, and quality assurance initiatives across the organization’s pan-India network.

Shreevar Kheruka appointed Managing Director at Borosil Limited
Shreevar Kheruka appointed Managing Director at Borosil Limited

By IPP Bureau - May 23, 2026

Kheruka has played a key role in transforming Borosil into a diversified, international consumer-focused enterprise

Fortis Healthcare  FY26 revenue crosses Rs. 9,100 crore
Fortis Healthcare FY26 revenue crosses Rs. 9,100 crore

By IPP Bureau - May 23, 2026

Q4 FY26 PAT jumps 44% to Rs. 271 crore, supported by acquisitions, specialty expansion, and diagnostics momentum

Latest Stories

Interviews

Packaging